Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

FDA approves axitinib for advanced renal cell carcinoma

Jan. 30, 2012

Infinity Pharmaceuticals completes preliminary analysis of saridegib/gemcitabine combination study

Jan. 30, 2012

FDA accepts bosutinib NDA for review

Jan. 30, 2012

Cancer Research UK begins study of AT-9283

Jan. 30, 2012

Scientists at Cellzome patent novel TYK2 inhibitors

Jan. 30, 2012

Merck KGaA patents new TGF-beta receptor type-1 inhibitors

Jan. 30, 2012

Pierre Fabre discloses new monoclonal antibodies for cancer

Jan. 30, 2012

Enrollment begins in Japan in phase III trials of orteronel

Jan. 27, 2012

EMA grants orphan drug status to Celator product

Jan. 27, 2012

RPCI launches first-ever trial of dendritic vaccine plus rapamycin

Jan. 27, 2012

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...